Clinical Trial Update: Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cangrelor to standard therapy for platelet inhibition in patients with atherosclerosis and acute coronary syndrome was terminated, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome

Drugs mentioned

• Kengreal (cangrelor)

Snippet

Sponsor: The Medicines Company | Conditions: Atherosclerosis, Acute Coronary Syndrome (ACS) | Phase 3 | Status: TERMINATED | Results posted: 2014-04-21